Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 5Fatigue 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Central Nervous System Neoplasms 2Sleep Wake Disorders 1Oligodendroglioma 1Neurofibromatosis 1 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Meningioma 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Depression 1Astrocytoma 1

Interventions

Radiosurgery 2Psychiatric Rehabilitation 2Vorinostat 1Uncertainty 1Therapeutics 1Temozolomide 1Radiotherapy 1Psychosocial Intervention 1Physical Examination 1Methylphenidate 1Magnetic Resonance Spectroscopy 1Duloxetine Hydrochloride 1Cognitive Behavioral Therapy 1Caregivers 1Behavior Therapy 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Depression × Methylphenidate × CNS × Clear all
NCT00031798 2021-09-09

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Wake Forest University Health Sciences

Phase 3 Terminated
CNSSarcoma

Astrocytoma, Brain Neoplasms, Depression, Ependymoma, Fatigue, Glioblastoma, Glioma, Meningioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡